Industry News

FDA approves first treatment for a condition associated with early-onset pediatric cataracts

The US Food and Drug Administration (FDA) approved Ctexli™ (chenodiol) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. This is the first FDA-approved treatment for CTX, which is a rare lipid storage disease that can be associated with pediatric bilateral cataracts. The approval was based on results from a...